Cargando…

The immune landscape of solid pediatric tumors

BACKGROUND: Large immunogenomic analyses have demonstrated the prognostic role of the functional orientation of the tumor microenvironment in adult solid tumors, this variable has been poorly explored in the pediatric counterpart. METHODS: We performed a systematic analysis of public RNAseq data (TA...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherif, Shimaa, Roelands, Jessica, Mifsud, William, Ahmed, Eiman I., Raynaud, Christophe M., Rinchai, Darawan, Sathappan, Abbirami, Maaz, Ata, Saleh, Ayman, Ozer, Erdener, Fakhro, Khalid A., Mifsud, Borbala, Thorsson, Vésteinn, Bedognetti, Davide, Hendrickx, Wouter R. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188257/
https://www.ncbi.nlm.nih.gov/pubmed/35690832
http://dx.doi.org/10.1186/s13046-022-02397-z
_version_ 1784725334786048000
author Sherif, Shimaa
Roelands, Jessica
Mifsud, William
Ahmed, Eiman I.
Raynaud, Christophe M.
Rinchai, Darawan
Sathappan, Abbirami
Maaz, Ata
Saleh, Ayman
Ozer, Erdener
Fakhro, Khalid A.
Mifsud, Borbala
Thorsson, Vésteinn
Bedognetti, Davide
Hendrickx, Wouter R. L.
author_facet Sherif, Shimaa
Roelands, Jessica
Mifsud, William
Ahmed, Eiman I.
Raynaud, Christophe M.
Rinchai, Darawan
Sathappan, Abbirami
Maaz, Ata
Saleh, Ayman
Ozer, Erdener
Fakhro, Khalid A.
Mifsud, Borbala
Thorsson, Vésteinn
Bedognetti, Davide
Hendrickx, Wouter R. L.
author_sort Sherif, Shimaa
collection PubMed
description BACKGROUND: Large immunogenomic analyses have demonstrated the prognostic role of the functional orientation of the tumor microenvironment in adult solid tumors, this variable has been poorly explored in the pediatric counterpart. METHODS: We performed a systematic analysis of public RNAseq data (TARGET) for five pediatric tumor types (408 patients): Wilms tumor (WLM), neuroblastoma (NBL), osteosarcoma (OS), clear cell sarcoma of the kidney (CCSK) and rhabdoid tumor of the kidney (RT). We assessed the performance of the Immunologic Constant of Rejection (ICR), which captures an active Th1/cytotoxic response. We also performed gene set enrichment analysis (ssGSEA) and clustered more than 100 well characterized immune traits to define immune subtypes and compared their outcome. RESULTS: A higher ICR score was associated with better survival in OS and high risk NBL without MYCN amplification but with poorer survival in WLM. Clustering of immune traits revealed the same five principal modules previously described in adult tumors (TCGA). These modules divided pediatric patients into six immune subtypes (S1-S6) with distinct survival outcomes. The S2 cluster showed the best overall survival, characterized by low enrichment of the wound healing signature, high Th1, and low Th2 infiltration, while the reverse was observed in S4. Upregulation of the WNT/Beta-catenin pathway was associated with unfavorable outcomes and decreased T-cell infiltration in OS. CONCLUSIONS: We demonstrated that extracranial pediatric tumors could be classified according to their immune disposition, unveiling similarities with adults’ tumors. Immunological parameters might be explored to refine diagnostic and prognostic biomarkers and to identify potential immune-responsive tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02397-z.
format Online
Article
Text
id pubmed-9188257
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91882572022-06-12 The immune landscape of solid pediatric tumors Sherif, Shimaa Roelands, Jessica Mifsud, William Ahmed, Eiman I. Raynaud, Christophe M. Rinchai, Darawan Sathappan, Abbirami Maaz, Ata Saleh, Ayman Ozer, Erdener Fakhro, Khalid A. Mifsud, Borbala Thorsson, Vésteinn Bedognetti, Davide Hendrickx, Wouter R. L. J Exp Clin Cancer Res Research BACKGROUND: Large immunogenomic analyses have demonstrated the prognostic role of the functional orientation of the tumor microenvironment in adult solid tumors, this variable has been poorly explored in the pediatric counterpart. METHODS: We performed a systematic analysis of public RNAseq data (TARGET) for five pediatric tumor types (408 patients): Wilms tumor (WLM), neuroblastoma (NBL), osteosarcoma (OS), clear cell sarcoma of the kidney (CCSK) and rhabdoid tumor of the kidney (RT). We assessed the performance of the Immunologic Constant of Rejection (ICR), which captures an active Th1/cytotoxic response. We also performed gene set enrichment analysis (ssGSEA) and clustered more than 100 well characterized immune traits to define immune subtypes and compared their outcome. RESULTS: A higher ICR score was associated with better survival in OS and high risk NBL without MYCN amplification but with poorer survival in WLM. Clustering of immune traits revealed the same five principal modules previously described in adult tumors (TCGA). These modules divided pediatric patients into six immune subtypes (S1-S6) with distinct survival outcomes. The S2 cluster showed the best overall survival, characterized by low enrichment of the wound healing signature, high Th1, and low Th2 infiltration, while the reverse was observed in S4. Upregulation of the WNT/Beta-catenin pathway was associated with unfavorable outcomes and decreased T-cell infiltration in OS. CONCLUSIONS: We demonstrated that extracranial pediatric tumors could be classified according to their immune disposition, unveiling similarities with adults’ tumors. Immunological parameters might be explored to refine diagnostic and prognostic biomarkers and to identify potential immune-responsive tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-022-02397-z. BioMed Central 2022-06-11 /pmc/articles/PMC9188257/ /pubmed/35690832 http://dx.doi.org/10.1186/s13046-022-02397-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sherif, Shimaa
Roelands, Jessica
Mifsud, William
Ahmed, Eiman I.
Raynaud, Christophe M.
Rinchai, Darawan
Sathappan, Abbirami
Maaz, Ata
Saleh, Ayman
Ozer, Erdener
Fakhro, Khalid A.
Mifsud, Borbala
Thorsson, Vésteinn
Bedognetti, Davide
Hendrickx, Wouter R. L.
The immune landscape of solid pediatric tumors
title The immune landscape of solid pediatric tumors
title_full The immune landscape of solid pediatric tumors
title_fullStr The immune landscape of solid pediatric tumors
title_full_unstemmed The immune landscape of solid pediatric tumors
title_short The immune landscape of solid pediatric tumors
title_sort immune landscape of solid pediatric tumors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188257/
https://www.ncbi.nlm.nih.gov/pubmed/35690832
http://dx.doi.org/10.1186/s13046-022-02397-z
work_keys_str_mv AT sherifshimaa theimmunelandscapeofsolidpediatrictumors
AT roelandsjessica theimmunelandscapeofsolidpediatrictumors
AT mifsudwilliam theimmunelandscapeofsolidpediatrictumors
AT ahmedeimani theimmunelandscapeofsolidpediatrictumors
AT raynaudchristophem theimmunelandscapeofsolidpediatrictumors
AT rinchaidarawan theimmunelandscapeofsolidpediatrictumors
AT sathappanabbirami theimmunelandscapeofsolidpediatrictumors
AT maazata theimmunelandscapeofsolidpediatrictumors
AT salehayman theimmunelandscapeofsolidpediatrictumors
AT ozererdener theimmunelandscapeofsolidpediatrictumors
AT fakhrokhalida theimmunelandscapeofsolidpediatrictumors
AT mifsudborbala theimmunelandscapeofsolidpediatrictumors
AT thorssonvesteinn theimmunelandscapeofsolidpediatrictumors
AT bedognettidavide theimmunelandscapeofsolidpediatrictumors
AT hendrickxwouterrl theimmunelandscapeofsolidpediatrictumors
AT sherifshimaa immunelandscapeofsolidpediatrictumors
AT roelandsjessica immunelandscapeofsolidpediatrictumors
AT mifsudwilliam immunelandscapeofsolidpediatrictumors
AT ahmedeimani immunelandscapeofsolidpediatrictumors
AT raynaudchristophem immunelandscapeofsolidpediatrictumors
AT rinchaidarawan immunelandscapeofsolidpediatrictumors
AT sathappanabbirami immunelandscapeofsolidpediatrictumors
AT maazata immunelandscapeofsolidpediatrictumors
AT salehayman immunelandscapeofsolidpediatrictumors
AT ozererdener immunelandscapeofsolidpediatrictumors
AT fakhrokhalida immunelandscapeofsolidpediatrictumors
AT mifsudborbala immunelandscapeofsolidpediatrictumors
AT thorssonvesteinn immunelandscapeofsolidpediatrictumors
AT bedognettidavide immunelandscapeofsolidpediatrictumors
AT hendrickxwouterrl immunelandscapeofsolidpediatrictumors